Eur J Prev Cardiol 31:12601273 Hankosky ER, Wang H, Neff LM et al (2024) Tirzepatide reduces the predicted risk of atherosclerotic cardiovascular disease and improves cardiometabolic risk factors in adults with obesity or overweight: SURMOUNT-1 post hoc analysis
Its packed with ingredients that nourish your gut, balance your blood sugar, and help you feel more satisfied after meals, all in a tasty, convenient sachet
Wang J, Xiong X, Feng B
2 Rybelsus 14 mg: -1.1% HbA1c reduction, -2.3 kg weight loss vs placebo These results confirm oral semaglutide is effective for blood sugar control, though the weight loss is modest compared to injectable options These are different trials with different designs, so a direct comparison of the numbers is limited
Discontinuation rates differ based on underlying medical conditions
Inflammation is reduced, but immune balance is not restored